An Extracellular Matrix Overlay Model for Bioluminescence Microscopy to Measure Single-Cell Heterogeneous Responses to Antiandrogens in Prostate Cancer Cells.


Journal

Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191

Informations de publication

Date de publication:
05 Apr 2024
Historique:
received: 12 02 2024
revised: 23 03 2024
accepted: 28 03 2024
medline: 26 4 2024
pubmed: 26 4 2024
entrez: 26 4 2024
Statut: epublish

Résumé

Prostate cancer (PCa) displays diverse intra-tumoral traits, impacting its progression and treatment outcomes. This study aimed to refine PCa cell culture conditions for dynamic monitoring of androgen receptor (AR) activity at the single-cell level. We introduced an extracellular matrix-Matrigel (ECM-M) culture model, enhancing cellular tracking during bioluminescence single-cell imaging while improving cell viability. ECM-M notably tripled the traceability of poorly adherent PCa cells, facilitating robust single-cell tracking, without impeding substrate permeability or AR response. This model effectively monitored AR modulation by antiandrogens across various PCa cell lines. Single-cell imaging unveiled heterogeneous antiandrogen responses within populations, correlating non-responsive cell proportions with drug IC50 values. Integrating ECM-M culture with the PSEBC-TSTA biosensor enabled precise characterization of ARi responsiveness within diverse cell populations. Our ECM-M model stands as a promising tool to assess heterogeneous single-cell treatment responses in cancer, offering insights to link drug responses to intracellular signaling dynamics. This approach enhances our comprehension of the nuanced and dynamic nature of PCa treatment responses.

Identifiants

pubmed: 38667168
pii: bios14040175
doi: 10.3390/bios14040175
pii:
doi:

Substances chimiques

Androgen Antagonists 0
Receptors, Androgen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : PCC Movember New investigator pilot grant
ID : 2012-933
Organisme : PCC Movember Rising Star Grants
ID : RS2014-04
Organisme : Fonds de recherche du Québec
ID : FRQS-35020
Organisme : Canadian Foundation for Innovation
ID : 32441
Organisme : Fonds de Recherche du Québec - Santé
ID : FRQS-34894

Auteurs

Audrey Champagne (A)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Imene Chebra (I)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Pallavi Jain (P)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Cassandra Ringuette Goulet (C)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Annie Lauzier (A)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Antoine Guyon (A)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Bertrand Neveu (B)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Frédéric Pouliot (F)

Centre de Recherche du CHU de Québec, Université Laval, Quebec, QC G1V 4G2, Canada.
Department of Surgery (Urology), Faculty of Medicine, Laval University, Quebec, QC G1R 2J6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH